Results 31 to 40 of about 23,298,365 (315)

EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression

open access: yesClinical and Translational Medicine, 2020
Background The EGFR-vIII mutation is the most common malignant event in GBM. Epigenetic reprogramming in EGFR-activated GBM has recently been suggested to downregulate the expression of tumour suppressor genes.
Hongyu Zhao   +10 more
doaj   +1 more source

Women in the field of multiple sclerosis: How they contributed to paradigm shifts

open access: yesFrontiers in Molecular Neuroscience, 2023
History is full of women who made enormous contributions to science. While there is little to no imbalance at the early career stage, a decreasing proportion of women is found as seniority increases.
Andreia Barateiro   +8 more
doaj   +1 more source

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis [PDF]

open access: yes, 2022
BACKGROUND: Drivers of differences in disease presentation and symptom duration in Lyme neuroborreliosis (LNB) are currently unknown. OBJECTIVES: We hypothesized that neurofilament light (NfL) in cerebrospinal fluid (CSF) would predict disease location ...
Gynthersen, Rosa M. M.   +23 more
core   +1 more source

Lipotropin and the Central Nervous System

open access: yes, 1977
Publisher Summary This chapter deals with the interaction of the lipotropin fragments and related peptides with the central nervous system (CNS). Peptides containing ACTH 4-10, in general, stimulate firing rate, excitability of neurons and neurotransmission, increase cAMP levels, and counteract some morphine-induced CNS effects (inhibition of spinal ...
Gispen, W.H., Ree, J.M. van, Wied, D. de
openaire   +3 more sources

Peripheral and central nervous system involvement in a patient with primary Sjögren’s syndrome: a case report [PDF]

open access: yes, 2019
BACKGROUND: Primary Sjögren's syndrome is the second most common rheumatological disorder after rheumatoid arthritis. It typically presents as xerophthalmia and xerostomia in postmenopausal women.
Wagner, Franca   +7 more
core   +2 more sources

Exploration of cerebral vasospasm from the perspective of microparticles

open access: yesFrontiers in Neuroscience, 2022
Cerebral vasospasm is a frequently encountered clinical problem, especially in patients with traumatic brain injury and subarachnoid hemorrhage. Continued cerebral vasospasm can cause cerebral ischemia, even infarction and delayed ischemic neurologic ...
Yalong Gao   +7 more
doaj   +1 more source

Sarcoidosis of the central nervous system [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1973
Six patients with sarcoidosis of the central nervous system are described. Pathological confirmation was obtained by brain biopsy in two patients and at necropsy in two; in two patients the diagnosis was presumptive and was made on the evidence of multisystem involvement. The symptomatology, methods of diagnosis, and results of treatment are discussed.
A C, Douglas, A F, Maloney
openaire   +2 more sources

Notch-mediated re-specification of neuronal identity during central nervous system development [PDF]

open access: yes, 2021
Neuronal identity has long been thought of as immutable, so that once a cell acquires a specific fate, it is maintained for life.(1) Studies using the overexpression of potent transcription factors to experimentally reprogram neuronal fate in the mouse ...
Suzuki, Sachihiro C.   +7 more
core   +1 more source

12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brain

open access: yesJournal of Lipid Research, 2015
The enzyme 12/15-lipoxygenase (LOX) oxidizes various free fatty acids, including arachidonic acid (AA). In the brain, the principal 12/15-LOX metabolites of AA are 12(S)-HETE and 15(S)-HETE. PPARγ is a nuclear receptor whose activation is neuroprotective
Li Sun   +5 more
doaj   +1 more source

Actinomycosis of the Central Nervous System :

open access: yesJapanese Journal of Medical Mycology, 1968
In 1882 Ponfick1) reported the first case of actinomycosis of the central nervous system. Although more than 100 articles have described actinomycosis of the brain and spinal cord, most cases are insufficiently documented to substantiate the diagnosis2).
H, Ikemoto, N, Hazato, F, Matsumura
openaire   +3 more sources

Home - About - Disclaimer - Privacy